cyclobenzaprine HCl 5 MG Oral Tablet
- RxCUI
- 828320
- RxNorm name
- cyclobenzaprine HCl 5 MG Oral Tablet
- Display name
- cyclobenzaprine HCl 5 MG Oral Tablet
- Full name
- cyclobenzaprine HCl 5 MG Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:46
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CYCLOBENZAPRINE HYDROCHLORIDE | CYCLOBENZAPRINE HYDROCHLORIDE | REMEDYREPACK INC. | 5d536e88-62be-45bd-bd09-0efc53fe12b9 | 2026-09-09 | Warnings, Adverse reactions | 828320 |
| Cyclobenzaprine hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Sportpharm LLC | 71185d15-3fd7-42b7-83a6-8357e3aaef43 | 2026-09-05 | Warnings, Adverse reactions | 828320 |
| Cyclobenzaprine hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | REMEDYREPACK INC. | eb2b24b1-2851-440f-9075-b6a123a1fd5c | 2026-08-05 | Warnings, Adverse reactions | 828320 |
| CYCLOBENZAPRINE HYDROCHLORIDE | CYCLOBENZAPRINE HYDROCHLORIDE | REMEDYREPACK INC. | f2eb32c3-3da0-4938-9ed9-ea8420450fde | 2026-07-27 | Warnings, Adverse reactions | 828320 |
| CYCLOBENZAPRINE HYDROCHLORIDE | CYCLOBENZAPRINE HYDROCHLORIDE | TruPharma LLC | 08adc97f-feef-46fb-ac75-f015b4f3a43a | 2026-07-17 | Warnings, Adverse reactions | 828320 |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE | Cipla USA Inc. | 575a31fb-04c5-4001-88a7-c33adbacc6a8 | 2026-07-08 | Warnings, Adverse reactions | 828320 |
| Cyclobenzaprine hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | 106d9730-5938-8f27-e063-6294a90adc68 | 2026-06-23 | Warnings, Adverse reactions | 828320 |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Major Pharmaceuticals | 508e310e-067a-4f95-869a-e1da49aabe94 | 2026-05-21 | Warnings, Adverse reactions | 828320 |
| CYCLOBENZAPRINE HYDROCHLORIDE | CYCLOBENZAPRINE HYDROCHLORIDE | ST. MARY'S MEDICAL PARK PHARMACY | 00b20a8c-debd-e930-e063-6394a90a7ed0 | 2026-05-20 | Warnings, Adverse reactions | 828320 |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Teva Pharmaceuticals USA, Inc. | 1d9e34cc-eee9-4147-abf8-c810a80e39d2 | 2026-05-01 | Warnings, Adverse reactions | 828320 |
| CYCLOBENZAPRINE HYDROCHLORIDE | CYCLOBENZAPRINE HYDROCHLORIDE | Coupler LLC | 5023b8a5-c9df-84a4-e063-6294a90a9606 | 2026-04-23 | Warnings, Adverse reactions | 828320 |
| CYCLOBENZAPRINE HYDROCHLORIDE | CYCLOBENZAPRINE HYDROCHLORIDE | QPharma, Inc. | 4dcbdf8f-37ce-0f90-e063-6394a90ae83c | 2026-04-10 | Warnings, Adverse reactions | 828320 |
| CYCLOBENZAPRINE HYDROCHLORIDE | CYCLOBENZAPRINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | e4e8bab3-c5e7-4d2b-9692-ee6c6799b120 | 2026-04-01 | Warnings, Adverse reactions | 828320 |
| Cyclobenzaprine hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | ac8ae965-af50-41d3-8df5-ca6daf4bbd1c | 2026-04-01 | Warnings, Adverse reactions | 828320 |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 29ca9548-23b0-4c50-82cb-4f0564d7e065 | 2026-04-01 | Warnings, Adverse reactions | 828320 |
| CYCLOBENZAPRINE HYDROCHLORIDE | CYCLOBENZAPRINE HYDROCHLORIDE | DirectRx | cdc5b438-6b6b-0cdd-e053-2a95a90a7f75 | 2026-03-06 | Warnings, Adverse reactions | 828320 |
| CYCLOBENZAPRINE HYDROCHLORIDE | CYCLOBENZAPRINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 4eaa675a-c24c-4043-8fdf-9d59e5e4f4d5 | 2026-01-22 | Warnings, Adverse reactions | 828320 |
| CYCLOBENZAPRINE HYDROCHLORIDE | CYCLOBENZAPRINE HYDROCHLORIDE | Medcore LLC | 1b834bd5-9ee6-42a4-819c-5c605fd18e1f | 2026-01-16 | Warnings, Adverse reactions | 828320 |
| CYCLOBENZAPRINE HYDROCHLORIDE | CYCLOBENZAPRINE HYDROCHLORIDE | Advagen Pharma Limited | b2169957-9083-412c-a175-3071860c2b43 | 2026-01-13 | Warnings, Adverse reactions | 828320 |
| Cyclobenzaprine Hydrochloride | CYCLOBENZAPRINE HYDROCHLORIDE | NORTHSTAR RX LLC | 2a3a13c3-116c-4e9e-a7f3-7ad7c80486c3 | 2026-01-02 | Warnings, Adverse reactions | 828320 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| fa8ea64a-62e7-4bbc-a4d3-4fee53cf21c7 | cyclobenzaprine HCl 5 MG Oral Tablet [PSN] · cyclobenzaprine hydrochloride 5 MG Oral Tablet [SCD] | 2 | 2 | CYCLOBENZAPRINE HYDROCHLORIDE TABLETS, USP Rx only | 20130718 |
| 5023b8a5-c9df-84a4-e063-6294a90a9606 | cyclobenzaprine HCl 5 MG Oral Tablet [PSN] · cyclobenzaprine hydrochloride 5 MG Oral Tablet [SCD] | 2 | 1 | Cyclobenzaprine hydrochloride, USP | 20260423 |
| 4dcbdf8f-37ce-0f90-e063-6394a90ae83c | cyclobenzaprine HCl 5 MG Oral Tablet [PSN] · cyclobenzaprine hydrochloride 5 MG Oral Tablet [SCD] | 2 | 1 | Cyclobenzaprine hydrochloride, USP | 20260410 |
| 6018b6e9-938d-4fc9-86d7-1fd1d7bfcc58 | cyclobenzaprine HCl 5 MG Oral Tablet [PSN] · cyclobenzaprine hydrochloride 5 MG Oral Tablet [SCD] | 2 | 1 | CYCLOBENZAPRINE HYDROCHLORIDE- cyclobenzaprine hydrochloride tablet, film coated Rising Pharma Holdings, Inc. | 20250220 |
| e332763b-00c6-41bf-84ae-a07d9ef79697 | cyclobenzaprine HCl 5 MG Oral Tablet [PSN] · cyclobenzaprine hydrochloride 5 MG Oral Tablet [SCD] | 2 | 1 | Cyclobenzaprine hydrochloride Tablets, USP | 20240611 |
| 32da07a1-2b0c-44bb-a3b4-31ba8274d226 | cyclobenzaprine HCl 5 MG Oral Tablet [PSN] · cyclobenzaprine hydrochloride 5 MG Oral Tablet [SCD] | 2 | 1 | Cyclobenzaprine Hydrochloride Tablets, USP Rx only | 20230711 |
| f8dec4e2-3151-4a79-b194-a11a57ada0b6 | cyclobenzaprine HCl 5 MG Oral Tablet [PSN] · cyclobenzaprine hydrochloride 5 MG Oral Tablet [SCD] | 2 | 1 | Cyclobenzaprine Hydrochloride Tablets, USP Rx Only | 20220903 |
| e3998083-e3db-4052-9b5b-19d7aaa4e658 | cyclobenzaprine HCl 5 MG Oral Tablet [PSN] · cyclobenzaprine hydrochloride 5 MG Oral Tablet [SCD] | 2 | 1 | Cyclobenzaprine Hydrochloride Tablets, USP Rx only | 20220701 |
| eb94a3f6-24dd-4847-8c05-22c49b853655 | cyclobenzaprine HCl 5 MG Oral Tablet [PSN] · cyclobenzaprine hydrochloride 5 MG Oral Tablet [SCD] | 2 | 1 | Cyclobenzaprine hydrochloride Tablets, USP | 20220330 |
| 0280b504-4a42-44f3-8a1a-34a20eac054a | cyclobenzaprine HCl 5 MG Oral Tablet [PSN] · cyclobenzaprine hydrochloride 5 MG Oral Tablet [SCD] | 2 | 1 | Cyclobenzaprine Hydrochloride Tablets, USP Rx only | 20210526 |
| 62f5bba6-23dd-47cd-9786-61be07646da7 | cyclobenzaprine HCl 5 MG Oral Tablet [PSN] · cyclobenzaprine hydrochloride 5 MG Oral Tablet [SCD] | 2 | 1 | Cyclobenzaprine Hydrochloride Tablets, USP Revised: August 2016 Rx Only | 20201221 |
| 7ac0f019-e673-4348-af62-27e0277770fa | cyclobenzaprine HCl 5 MG Oral Tablet [PSN] · cyclobenzaprine hydrochloride 5 MG Oral Tablet [SCD] | 2 | 1 | CYCLOBENZAPRINE HYDROCHLORIDE TABLETS, USP Rx only | 20180813 |
| 5f8ab159-7b80-b3f2-e053-2a91aa0ae2d7 | cyclobenzaprine HCl 5 MG Oral Tablet [PSN] · cyclobenzaprine hydrochloride 5 MG Oral Tablet [SCD] | 2 | 1 | 20171204 | |
| 119094a0-1c9a-49cf-e054-00144ff88e88 | cyclobenzaprine HCl 5 MG Oral Tablet [PSN] · cyclobenzaprine hydrochloride 5 MG Oral Tablet [SCD] | 2 | 1 | CYCLOBENZAPRINE HYDROCHLORIDE TABLETS, USP | 20150318 |
| c62f6022-aafd-456e-b52c-99cd1cc5c3c6 | cyclobenzaprine HCl 5 MG Oral Tablet [PSN] · cyclobenzaprine hydrochloride 5 MG Oral Tablet [SCD] | 2 | 1 | Cyclobenzaprine Hydrochloride Tablets, USP | 20130909 |
| c68204a7-d00c-4ce7-bfda-bff58b2ed67e | cyclobenzaprine HCl 5 MG Oral Tablet [PSN] · cyclobenzaprine hydrochloride 5 MG Oral Tablet [SCD] | 2 | 1 | 20110603 | |
| 4eddf137-fd00-43d0-96ed-16f057806d4e | cyclobenzaprine HCl 5 MG Oral Tablet [PSN] · cyclobenzaprine hydrochloride 5 MG Oral Tablet [SCD] | 2 | 1 | 20100604 | |
| dd2d3cf8-293c-4c3b-bdce-81f5c6a220ef | cyclobenzaprine HCl 5 MG Oral Tablet [PSN] · cyclobenzaprine hydrochloride 5 MG Oral Tablet [SCD] | 2 | 1 | Cyclobenzaprine Hydrochloride Tablets, USP | 20100218 |